Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05585918 · ClinicalTrials.gov registry record · NA
The R-CITY Project: A Collaborative Intervention With Teachers and Youth
A NA study of Violence, sponsored by University of Virginia.
- Active
- Registry status
- NA
- Development phase
- 145
- Enrollment target
- 1
- Study location
NCT05585918: Active NA study of Violence, sponsored by University of Virginia.
NCT05585918 is a NA study of Violence that is active but no longer recruiting, run by University of Virginia. The registered enrollment target is 145 participants, below the 4,530-participant average among 19 other Violence trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05585918, a NA study of Violence, is active but no longer recruiting, sponsored by University of Virginia.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 145 participants
- Enrollment target
- 1
- Study location
Study Summary
"R-CITY" refers to the Collaborative Intervention with Teachers and Youth to practice and apply the 4 "Rs" of social skills in the classroom - Recognizing, Responding, Relationships, and Resilience. R-CITY is a collaborative teacher- and youth-focused prevention intervention that offers student lessons to accompany the Second Step curriculum. The lessons are designed to create safe and positive learning environments for all. The R-CITY Project uses a school-level randomized controlled trial (RCT) design to test the integration of the Second Step program that the school district had been scaling up district wide with the R-CITY lessons. The purpose of the RCT is to determine the "value-added" of the Second Step program plus the new skill content compared to the Second Step alone in elementary and middle schools. Students in both conditions get access to the Second Step content, as an active control condition.
Primary Outcome
The ASSIST is a direct observational measure that assesses the classroom interactions between students and teachers. Observation cycles are 15 minutes and scales include tallied counts of teacher and student behaviors, as well as global ratings of interactions based on a Likert-style scale.
Conditions Studied
Interventions
- BEHAVIORAL Second Step + R-CITY
- BEHAVIORAL Second Step Only
Study Locations (1)
Maryland
- Shepard Pratt Health System - Towson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2021-09-15 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
What the registry record for NCT05585918 still lists
NCT05585918 is an interventional study that assigns participants to a tested intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap, below the 4,530-participant average among 19 other Violence trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Violence appearing as the primary indexed condition, and to 2 interventions - of which Second Step + R-CITY is the first listed.
NCT05585918 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05585918 about?
NCT05585918 is a clinical study titled "The R-CITY Project: A Collaborative Intervention With Teachers and Youth". "R-CITY" refers to the Collaborative Intervention with Teachers and Youth to practice and apply the 4 "Rs" of social skills in the classroom - Recognizing, Responding, Relationships, and Resilience. R-CITY is a collaborative teacher- and youth-focused prevention intervention that offers student less...
What is the current status of trial NCT05585918?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 145 participants. The study started on 2021-09-15. Estimated completion is 2026-11-30.
What conditions does trial NCT05585918 study?
This clinical trial studies the following conditions: Violence.
What interventions are being tested in trial NCT05585918?
The interventions under investigation include: Second Step + R-CITY (BEHAVIORAL), Second Step Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT05585918?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05585918 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Violence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05585918's enrollment target sits among peer trials
145 19th of 19 higher than 1 of 19 other Violence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Violence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Evidence-based Family Support Program for Parents and Children in Palestine: a Theory-based Intervention
RECRUITING · NA
-
Preventing Retaliatory Gun Violence in Violently Injured Adults
RECRUITING · NA
-
#ChopViolence/#ChopHIV
RECRUITING · NA
-
A Hospital-based Intervention for Youth Injured Through Violence
RECRUITING · NA
-
Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study
RECRUITING · NA
-
A Virtual Reality Brief Violence Intervention: Preventing Gun Violence Among Violently Injured Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02688959 · 145 participants · NA
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
- NCT03586609 · 145 participants · Phase 2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- NCT03767595 · 145 participants · NA
ProACT Post-Approval Study
- NCT03808337 · 145 participants · Phase 2
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI